The Radiotherapeutic Factors Associated with Reduced Risk of Progression in Patients with Oligometastatic Non-Small Cell Lung Cancer Treated with Local Ablative Radiotherapy

被引：0
|
作者：
Yang, G. [1 ]
Kim, K. H. [1 ]
Lee, C. G., Jr. [1 ]
Yoon, H. I. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2910
引用
收藏
页码：E408 / E408
页数：1
相关论文
共 50 条
  • [31] Prognostic factors for control of early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
    Charlton, Thomas
    Hindocha, Sumeet
    Hanumanthappa, Nikesh
    Smith, Daniel
    Vivekanandan, Sindu
    Taylor, Benjamin
    Skwarski, Michael
    Ahmad, Shahreen
    LUNG CANCER, 2021, 156 : S60 - S61
  • [32] Oligometastatic Non-Small Cell Lung Cancer Treated With Curative Intent
    Walker, P.
    Rosenman, J.
    Arastu, H.
    Leinweber, C.
    Aljumaily, R.
    Biswas, T.
    Russo, S.
    Parent, T.
    Eubanks, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S48 - S48
  • [33] Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer
    Miller, Douglas A.
    Krasna, Mark J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 611 - +
  • [34] Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
    Santos, Patricia Mae G.
    Li, Xingzhe
    Gomez, Daniel R.
    CANCERS, 2022, 14 (16)
  • [35] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Dhaliwal, Inderdeep
    Kassirian, Shayan
    Mitchell, Michael A.
    Qiabi, Mehdi
    Warner, Andrew
    Louie, Alexander, V
    Wong, Harvey H.
    McDonald, Christine M.
    Rajchgot, Jason
    Palma, David A.
    BMC CANCER, 2022, 22 (01)
  • [36] A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
    Tonneau, Marion
    Richard, Corentin
    Routy, Bertrand
    Campeau, Marie-Pierre
    Vu, Toni
    Filion, Edith
    Roberge, David
    Mathieu, Dominique
    Doucet, Robert
    Beliveau-Nadeau, Dominic
    Bahig, Houda
    RADIOTHERAPY AND ONCOLOGY, 2023, 185
  • [37] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Inderdeep Dhaliwal
    Shayan Kassirian
    Michael A. Mitchell
    Mehdi Qiabi
    Andrew Warner
    Alexander V. Louie
    Harvey H. Wong
    Christine M. McDonald
    Jason Rajchgot
    David A. Palma
    BMC Cancer, 22
  • [38] Local consolidative therapy for oligometastatic non-small cell lung cancer
    Samson, Pamela P.
    Spraker, Matthew B.
    Badiyan, Shahed N.
    Vlacich, Gregory
    Robinson, Clifford G.
    Chaudhuri, Aadel A.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5649 - 5651
  • [39] Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
    Agolli, Linda
    Valeriani, Maurizio
    Nicosia, Luca
    Bracci, Stefano
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    Osti, Mattia Falchetto
    ANTICANCER RESEARCH, 2015, 35 (11) : 6239 - 6245
  • [40] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
    McDonald, F.
    Mak, K. M.
    Teague, J.
    Landau, D.
    Hanna, G.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2020, 139 : S91 - S91
12345